Structure |
Chemical Name |
CAS |
MF |
 |
Acetamide, N-(4-hydroxyphenyl)-N-nitroso- |
146897-60-1 |
C8H8N2O3 |
![3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-](/CAS/20210305/GIF/2402776-83-2.gif) |
3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]- |
2402776-83-2 |
C16H17N7O2S |
 |
Iohexol ImpuritiesE |
|
|
 |
TERT-BUTYL (R)-6-CHLORO-5-HYDROXY-3-OXOHEXANOATE |
404958-08-3 |
C10H17ClO4 |
![2-(3-(4-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile](/) |
2-(3-(4-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile |
|
|
![8-chloro-11-(1-((5-methylpyridin-3-yl)methyl)piperidin-4-yl)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine](/) |
8-chloro-11-(1-((5-methylpyridin-3-yl)methyl)piperidin-4-yl)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine |
|
|
 |
Bumetanide Photodegradable Impurity 16 |
|
|
 |
Bisoprolol Impurity 47 |
|
|
 |
Gadobutrol Impurity 11(Ammonium salt) |
|
|
 |
Flomoxef Impurity F |
|
|
 |
Tegoprazan Impurity 15 |
|
|
 |
Nirmatrelvir Impurity 8 |
|
|
 |
Nirmatrelvir Impurity 2 |
|
|
 |
(5-(2-fluorophenyl)-1H-pyrrol-3-yl)methanamine hydrochloride |
|
|
 |
Rocuronium Bromide Impurity 24 、25 |
|
|
 |
Roxadustat Impurity 17 |
|
|
 |
Perospirone Impurity 20 |
1002359-81-0 |
|
 |
Dolutegravir Impurity 19 |
|
|
 |
Cephalexin Impurity I |
|
|
 |
Fondaparinux sodium impurity 6 |
|
|
 |
Fondaparinux sodium impurity 2 |
|
|
 |
Oxacillin sodium Impurity I |
|
|
 |
Mixture of Cefoxitin Impurity E&F |
|
|
 |
Revefenacin Impurity 22 |
|
|
 |
Lasmiditan Impurity 7 |
|
|
 |
Febuxostat impurity BAC |
|
|
 |
4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENOL |
866018-46-4 |
C16H14Cl2O |
 |
Lasmiditan Impurity 9 |
|
|
 |
Letermovir Impurity 2 |
|
|
 |
1H-イミダゾール-2-カルボン酸 |
16042-25-4 |
C4H4N2O2 |
 |
Olodaterol Impurity 19 |
|
|
 |
Ethacridine Impurity 12 |
|
|
![[2R,2'S,αS,α'S,(-)]-α,α'-[イミノビス(メチレン)]ビス(6-フルオロ-3,4-ジヒドロ-2H-1-ベンゾピラン-2-メタノール)](/CAS/GIF/118457-16-2.gif) |
[2R,2'S,αS,α'S,(-)]-α,α'-[イミノビス(メチレン)]ビス(6-フルオロ-3,4-ジヒドロ-2H-1-ベンゾピラン-2-メタノール) |
118457-16-2 |
C22H25F2NO4 |
 |
5-Hydroxymethyl Flucloxacillin |
75524-31-1 |
C19H17ClFN3O6S |
 |
6-ヒドロキシ-5-メトキシ-1-インダノン |
90843-62-2 |
C10H10O3 |
 |
デホルミルビンクリスチン |
18172-50-4 |
C45H56N4O9 |
 |
ラベプラゾールスルホン |
117976-47-3 |
C18H21N3O4S |
 |
6-ブロモ-3H-イソベンズオフラン-1-オン |
19477-73-7 |
C8H5BrO2 |
 |
TOPOTECANACETATE |
123948-88-9 |
C25H27N3O7 |
 |
dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarb oxylate |
21829-09-4 |
C17H18N2O6 |
 |
Metronidazole IMpurity (1-Methyl-4-Nitro-1H-IMidazole) |
143508-97-8 |
C2H3NO |
 |
(S)-Phenylephrine hydrochloride |
939-38-8 |
C9H14ClNO2 |
 |
L-erythro-3-(3,4-Dihydroxyphenyl)serine |
34047-62-6 |
C9H11NO5 |
 |
2-(メチルエチルアミノ)-N-(2,6-ジメチルフェニル)アセトアミド |
74634-66-5 |
C13H20N2O |
 |
リボフラビン3′,5′-ビスりん酸 |
86108-26-1 |
C17H22N4O12P2 |
 |
6 beta-hydroxycortisol |
53-35-0 |
C21H30O6 |
 |
16-hydroxyclarithromycin |
124412-58-4 |
C38H69NO14 |
 |
1-(4-イソブチルフェニル)エタノール |
40150-92-3 |
C12H18O |
 |
3-ヒドロキシフェニルトリメチルアンモニウムヨージド |
2498-27-3 |
C9H14INO |
 |
D-トリプトファンメチル |
22032-65-1 |
C12H14N2O2 |
![[(5Z)-5-ベンジリデン-4-オキソ-2-チオキソ-1,3-チアゾリジン-3-イル]酢酸](/CAS/GIF/82159-06-6.gif) |
[(5Z)-5-ベンジリデン-4-オキソ-2-チオキソ-1,3-チアゾリジン-3-イル]酢酸 |
82159-06-6 |
C12H9NO3S2 |
 |
3-ニトロ-1-エチニルベンゼン |
3034-94-4 |
C8H5NO2 |
 |
3-(4-メチル-1H-イミダゾール-1-イル)-5-(トリフルオロメチル)安息香酸 |
641571-13-3 |
C12H9F3N2O2 |
 |
4-(3-ブロモプロピル)モルホリン |
125422-83-5 |
C7H14BrNO |
![(6R,7S)-3-メチル-8-オキソ-7β-[(フェニルアセチル)アミノ]-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸](/CAS/GIF/27255-72-7.gif) |
(6R,7S)-3-メチル-8-オキソ-7β-[(フェニルアセチル)アミノ]-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸 |
27255-72-7 |
C16H16N2O4S |
 |
2-(1-オキソプロピル)安息香酸 |
2360-45-4 |
C10H10O3 |
 |
3-メトキシ-4-ヒドロキシフェニルアラニン |
300-48-1 |
C10H13NO4 |
 |
Triacetyl Aloe-emodin (Impurity A) |
25395-11-3 |
C21H16O8 |
 |
IMatinib DiPiperidine IMpurity |
|
|
 |
levocetirizine IMpurity |
|
|
 |
OseltaMivir IMpurity F |
|
|
 |
RocuroniuM BroMide IMpurity 19 |
|
|
 |
S-(+)-O-DesMethyl-Venlafaxine-d6 |
1062609-99-7 |
C16H25NO2 |
 |
SalMeterol IMpurity F |
|
C25H37NO4 |
 |
Sitagliptin Defuoro IMpurity 4 |
486459-98-7 |
C15H19F2NO4 |
 |
Sulpiride IMpurity F |
|
|
 |
イブプロフェン二量體 |
1391054-15-1 |
C26H32O4 |
 |
EthanediaMide iMpurity F |
480452-37-7 |
C16H22ClN5O3 |
 |
Paroxetine IMpurity |
|
|
![7-[(2-aMinoethyl)aMino] -1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](/CAS/20150408/GIF/CB92679157.gif) |
7-[(2-aMinoethyl)aMino] -1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
C14H16FN3O3 |
![(S)-(1R,3s,5S)-8-Methyl-8-azabicyclo[3.2.1]oct-6-en-3-yl 3-hydroxy-2-phenylpropanoate](/CAS/20150408/GIF/61616-97-5.gif) |
(S)-(1R,3s,5S)-8-Methyl-8-azabicyclo[3.2.1]oct-6-en-3-yl 3-hydroxy-2-phenylpropanoate |
61616-97-5 |
C17H21NO3 |
 |
AlviMopan iMpurity |
|
|
 |
Caspofungin iMpurity |
|
|
 |
Saxagliptin iMpurity |
2173146-35-3 |
C18H24ClN3O2 |
 |
PD 312237 |
501666-23-5 |
C20H35NO11 |
![(1R,5S,6S)-REL-5-(1-エチルプロポキシ)-7-オキサビシクロ[4.1.0]ヘプト-3-エン-3-カルボン酸メチルエステル](/CAS/GIF/1234858-94-6.gif) |
(1R,5S,6S)-REL-5-(1-エチルプロポキシ)-7-オキサビシクロ[4.1.0]ヘプト-3-エン-3-カルボン酸メチルエステル |
1234858-94-6 |
C13H20O4 |
 |
2-(DiethylaMino)-N-(2,3-diMethylphenyl)acetaMide Hydrochloride |
857170-72-0 |
C14H23ClN2O |
 |
4-Hydroxy Darunavir |
313682-97-2 |
C27H37N3O8S |
 |
3-(4'-カルボキシフェニル)-プロピオンアルデヒドエチルエステル |
151864-81-2 |
C12H14O3 |
 |
(2,6-Xylyloxy)acetyl Lopinavir |
943250-65-5 |
C47H58N4O7 |
 |
(S)-イソチモロール |
158636-96-5 |
C13H24N4O3S |
 |
Clopidogrel IMpurity 4 |
801319-16-4 |
C15H14ClNO2S |
 |
DiazepaM IMpurity F |
31269-33-7 |
C16H13ClN2O |
 |
LaMotrigine IMpurity |
|
|
 |
Posaconazole DiastereoisoMer interMediate 5 |
149809-42-7 |
C21H21F2N3O4S |
 |
1-シクロプロピル-2-(2-フルオロフェニル)-2-ヒドロキシエタノン |
1100905-45-0 |
C11H11FO2 |
 |
Solifenacin Related CoMpound 2 Succinate |
1262506-09-1 |
C27H32N2O6 |
 |
Tetrahydro FuroseMide |
4793-38-8 |
C12H15ClN2O5S |
 |
6-O-DesMethoxyethyl-6-O-chloroethyl Erlotinib Hydrochloride |
183320-04-9 |
C21H21Cl2N3O3 |
 |
Macitentan IMpurity |
556796-88-4 |
C17H15Br2N5O4S |
 |
4-((4-broMophenyl)(1H-1,2,4-triazol-1-yl)Methyl)benzonitrile |
143030-54-0 |
C16H11BrN4 |
![Acetic acid, 2-[2-[4-(diphenylMethyl)-1-piperazinyl]ethoxy]-](/CAS/20150408/GIF/83881-53-2.gif) |
Acetic acid, 2-[2-[4-(diphenylMethyl)-1-piperazinyl]ethoxy]- |
83881-53-2 |
C21H26N2O3 |
 |
Benazepril Related CoMpound B |
|
|
 |
IMatinib iMpurity |
152459-96-6 |
C24H21N5O |
 |
(2R,3R,4R,5S,6R)-2-(acetoxyMethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
|
C32H33FO9S |
![1,2-BenzenedicarboxaMide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]-](/CAS/20150408/GIF/1365267-36-2.gif) |
1,2-BenzenedicarboxaMide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
1365267-36-2 |
C36H36N6O10 |
 |
(4-メチルキナゾリン-2-イル)メタノール |
13535-91-6 |
C10H10N2O |
![5-(2,2-diMethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one](/CAS/20150408/GIF/452340-96-4.gif) |
5-(2,2-diMethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one |
452340-96-4 |
C13H15NO4 |
 |
alpha-(Dimethylaminomethyl)-alpha-ethylbenzyl alcohol hydrochloride |
104743-23-9 |
C12H20ClNO |
![N-[6,9-Dihydro-6-oxo-9-[[2-(1-oxopropoxy)-1-[(1-oxopropoxy)methyl]ethoxy]methyl]-1H-purin-2-yl]propanamide](/CAS/20150408/GIF/177216-32-9.gif) |
N-[6,9-Dihydro-6-oxo-9-[[2-(1-oxopropoxy)-1-[(1-oxopropoxy)methyl]ethoxy]methyl]-1H-purin-2-yl]propanamide |
177216-32-9 |
C18H25N5O7 |